Skip to content
Dose Brief
Menu
No. 375 here · Grade C

Invyncible review

Invyncible is a Florida-based telehealth platform that publishes every semaglutide and tirzepatide program price on its open catalog and names the six pharmacies that fill them.

Visit Invyncible Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $149/mo (0.45 mg dose, compounded with glycine + B12)
Tirzepatide
From $180/mo (2.5 mg weekly, 4-week program, compounded)
Coverage
46 states plus DC
Brand-name
Yes

Prices read from Invyncible's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— The first reading of this row recorded From $192/mo and reported that no price was published at all, which was wrong — it was read off the company homepage, which sells nothing. Re-read against the product catalog, the line is From $149/mo (0.45 mg dose, compounded with glycine + B12). Treat that as the first honest reading; there is no earlier one worth comparing against.

The scorecard

Invyncible scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability64/100
Transparency48/100
Access Breadth74/100
Clinical Oversight70/100
Track Record60/100

What we like

  • Prices every dose program on the open catalog — no account, no intake, no quiz
  • Names all six compounding pharmacies with street addresses and phone numbers, and lets the patient choose which fills the prescription
  • Separates compounded from FDA-approved brand and injection from oral right on the catalog: Wegovy $1,750, Zepbound $1,540, semaglutide capsules $255.50
  • Refills are requested rather than auto-billed, and the card is only charged if a provider approves
  • Corporate parent disclosed (Nationwide Telemedicine, LLC) with a St. Petersburg, FL address and a working, domain-specific LegitScript link

The caveats

  • The published figure is the smallest vial — plain compounded semaglutide steps to $262.50 at the 5 mg vial and $350 at the 10 mg, and the FAQ confirms cost rises with dose
  • Every price sits beside a permanently struck-through higher figure, which anchors rather than saves
  • None of the six named pharmacies carries a 503A or 503B designation on the site
  • Shipping is a separate charge at checkout with no published amount, and every GLP-1 is restricted to overnight cold
  • Compounded semaglutide is unavailable in six more states than the 46-state footprint, tirzepatide in seven

The brief

Best for: Readers who want to read the price of every dose program, and the pharmacy behind it, before starting an intake. Invyncible is a Florida-based telehealth platform that publishes every semaglutide and tirzepatide program price on its open catalog and names the six pharmacies that fill them.

Ranked #375 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Visit Invyncible

Before you decide

The questions readers ask next after reading about Invyncible.

Closest here

The providers scoring nearest Invyncible — the realistic shortlist if you're weighing it.

Weighing Invyncible against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Invyncible, and every provider that outranks it is listed on the Invyncible alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Invyncible's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Invyncible's site. Not medical advice; see our disclosure.

← Back to all rankings